Start:	Nov 27, 2024 - 2:30 pm
End:	Nov 27, 2024 - 4:30 pm
Venue:	Webinar
Event website:	https://era4health.eu/news/blogdetail.php?id=76

What is Effectrial?

EffecTrial, an ERA4Health initiative, aims to foster pragmatic comparative-effectiveness trials in the field of non-communicable diseases. These trials are critical for improving clinical decision-making by comparing the effectiveness of approved healthcare interventions, such as diagnostics, treatments, and lifestyle modifications, under real-world conditions. This transnational call encourages collaboration among healthcare organizations, research teams, and public health entities to conduct multi-country, investigator-initiated clinical studies (IICS).

The program targets major public health challenges, focusing on cardiovascular diseases, metabolic disorders, nutrition and lifestyle-related conditions, and non-communicable respiratory diseases. Projects are expected to demonstrate significant health, economic, and policy impacts, while adhering to Responsible Research and Innovation (RRI) principles and ethical guidelines. EffecTrial serves as a cornerstone for advancing collaborative research to benefit patients and citizens across Europe.

Joni the Effectrial info Day

The EffecTrial Info Day is a must-attend online event for researchers, clinicians, and organizations interested in the Joint Transnational Call (JTC) under the ERA4Health initiative. This session offers a deep dive into the funding opportunities for pragmatic comparative-effectiveness trials in non-communicable diseases.

The webinar agenda includes:

• Welcome Note and Introduction (Cristina Nieto, ERA4Health Coordinator)
  Overview of ERA4Health, including the partnership’s goals and Strategic Research and Innovation Agenda.
• Presentation of the “EffecTrial” Call (Astrid Valencia and Sara García-Rodríguez, Joint Call Secretariat):
  • Call objectives and scope.
  • Consortium requirements and eligibility rules.
  • Funding mechanisms and evaluation criteria.
  • Partner search tips and submission tool insights.
• Break: A brief 10-minute pause.
• Responsible Research and Innovation (RRI) (ERA4Health RRI Advisor):
  Learn how the principles of RRI shape the call and evaluation process.
• Interactive Q&A: Address your queries directly to the ERA4Health Coordination team, Joint Call Secretariat, and scientific experts via chat.

Supporting materials include the call text, applicant guidelines, and a pre-proposal template, available here.

How to join the webinar?

No registration required – simply join through the provided Zoom link (access code: 177383).

How is Nanomedicine relevant in Effectrial?

The European Technology Platform on Nanomedicine (ETPN) has recently highlighted the immense potential of nanomedicine to elevate the objectives of EffecTrial. By integrating cutting-edge drug delivery systems and precision medicine technologies, nanomedicine can play a pivotal role in optimizing treatments for cardiovascular, metabolic, and respiratory diseases as well as nutrition- and lifestyle-related conditions. These innovations align seamlessly with EffecTrial’s focus on real-world, comparative-effectiveness studies.

ETPN encourages all stakeholders in the nanomedicine field to actively engage with this call, leveraging its potential to advance patient-centric care and foster meaningful public health impact. To delve deeper into the relevance of nanomedicine in EffecTrial, visit our dedicated article: on Nanomedicine and EffecTrial

Let’s shape the future of healthcare together!